Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5M | $0 | $0 | $3.0M | $0 | $0 | $0 | $12.0M |
| Cost of revenue | $124.4K | $209.1K | $241.6K | $407.3K | $297.8K | $282.2K | $331.8K | $348.5K |
| Gross profit | $11.4M | −$209.1K | −$241.6K | $2.6M | −$297.8K | −$282.2K | −$331.8K | $11.7M |
| Gross margin | 98.9% | — | — | 86.4% | — | — | — | 97.1% |
| R&D | $13.1M | $30.6M | $31.8M | $16.6M | $9.3M | $22.0M | $38.0M | $42.5M |
| Operating income | −$8.7M | −$39.9M | −$42.3M | −$45.6M | −$16.5M | −$33.8M | −$47.9M | −$43.7M |
| EBITDA | −$8.4M | −$40.1M | −$41.4M | −$45.3M | −$15.4M | −$29.4M | −$47.3M | −$39.4M |
| Net income | −$9.0M | −$40.7M | −$42.2M | −$47.1M | −$17.9M | −$34.7M | −$51.4M | −$44.2M |
| Net margin | -78.4% | — | — | -1568.9% | — | — | — | -368.5% |
| EPS (diluted) | -6.92 | -31.28 | -28.16 | -29.00 | -9.32 | -10.64 | -14.72 | -10.76 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5M | $-10.40 | $-10.40–$-10.40 | 1 |
| 2027 | $4M | $-11.92 | $-11.92–$-11.92 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ASLN.
No tracked institution reports a position in ASLN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-07-03 | 1-for-8reverse |
| 2023-03-13 | 1-for-5reverse |
No one on the platform has traded ASLN yet.
| $633M |
| — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
| ICPTIntercept Pharmaceuticals, Inc. | $19.00 | +0.21% | $795M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ASLN APOGEE got BO for its AD drug. Freaking $10.9 B!
View on StockTwits ↗$ASLN have they went completely bankrupt? What’s the latest news? This is glitching my Robinhood account and showing me down $725 every single day, Robinhood said they can’t remove it because they are still working on compliance but it has been froze forever. I am just tired of my account looking like I’m down every single day. Oh and there is a kicker, it switches on Robinhood randomly so I jump back and forth from $725 down to whatever my true position is on all my other investments.
View on StockTwits ↗$ASLN hello.. Anyone in here? What is going on here😑
View on StockTwits ↗$ASLN News 15/04 08:02 ASLAN PHARMACEUTICALS LTD HC Wainwright & Co. analyst Yi Chen reiterates ASLAN Pharma (NASDAQ: ASLN) with a Buy and maintains $9 price target.
View on StockTwits ↗$ASLN Got charged again for ADR fees on 1/14. God damn it. What a curse to own this shit. How many times have we been charged for nothing?
View on StockTwits ↗$ASLN ......can't even put a sell order in or a buy what's going on..
View on StockTwits ↗$ASLN If anyone is tired of waiting for something to happen, I would be happy to buy your shares from you at $0.60 (the close on the last trading day). DM me for details. I'm short and while I'm not paying very expensive borrow I would like to clear this off my books and move on.
View on StockTwits ↗$ASLN What a call 🫡 Well take your word for $ALT
View on StockTwits ↗how many shares do you guys have i have 1k @ .60 $ASLN
View on StockTwits ↗$ASLN is this gonna be tradeable in Robinhood again ?
View on StockTwits ↗@Janedo @SQUEAKSBANDIT To summarize my understanding of a frustrating conversation w/ broker, we need to elect to tender ADR shares or let the tender offer expire. If the offer expires, the agent will close the ADR position & attempt to sell the shares & remit whatever cash they obtain to the holder. If you tender the ADRs, you'll receive 250 shares for each ADR but can't sell them without going directly to the broker. On your behalf, the broker can attempt to sell the shares on a "best-efforts" basis by locating a foreign broker to execute the trade, but there are no guarantees they'll be able to sell the shares. Per the offer terms, if you tender your ADR shares, there is a cable fee of $15, a cancelations fee of $.05 per ADR (rounding off to nearest 100 shares surrendered) and a voluntary $25 corporate action fee. While I liked the opportunity here, I think managing this position & the tax reporting will be more trouble than it's worth and comes with yet another charge. $ASLN
View on StockTwits ↗$ASLN would it benefit us in any way to convert to ordinary shares? could they even be held in a standard us brokerage account? do the ordinaries currently trade in Singapore?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.